Cargando…
Emerging role of tumor cell plasticity in modifying therapeutic response
Resistance to cancer therapy is a major barrier to cancer management. Conventional views have proposed that acquisition of resistance may result from genetic mutations. However, accumulating evidence implicates a key role of non-mutational resistance mechanisms underlying drug tolerance, the latter...
Autores principales: | Qin, Siyuan, Jiang, Jingwen, Lu, Yi, Nice, Edouard C., Huang, Canhua, Zhang, Jian, He, Weifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541492/ https://www.ncbi.nlm.nih.gov/pubmed/33028808 http://dx.doi.org/10.1038/s41392-020-00313-5 |
Ejemplares similares
-
Protein degradation: expanding the toolbox to restrain cancer drug resistance
por: Ming, Hui, et al.
Publicado: (2023) -
Redox regulation in tumor cell epithelial–mesenchymal transition: molecular basis and therapeutic strategy
por: Jiang, Jingwen, et al.
Publicado: (2017) -
A cellular thermal shift assay for detecting amino acid sites involved in drug target engagement
por: Peng, Liyuan, et al.
Publicado: (2022) -
Oral squamous cell carcinomas: state of the field and emerging directions
por: Tan, Yunhan, et al.
Publicado: (2023) -
Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies
por: Tian, Hailong, et al.
Publicado: (2022)